[Lys5, Tyr6, mLeu9, Nle10]-Neurokinin A (4-10)
[Lys5, Tyr6, mLeu9, Nle10]-Neurokinin A (4-10) (ID 305) is a selective NK2R agonist with an EC50 of 3.7 nM for hNK2R. [Lys5, Tyr6, mLeu9, Nle10]-Neurokinin A (4-10) significantly inhibits weight loss in diet-induced obese (DIO) mice model and improves Loperamide -induced dysfunctional voiding in wild-type mice. [Lys5, Tyr6, mLeu9, Nle10]-Neurokinin A (4-10) can be used for neurokinin receptor mediated disorders, such as obesity, insulin resistance and type 2 diabetes research[1].
Product Specifications
CAS Number
2770688-04-3
UNSPSC
12352209
Target
Neurokinin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Metabolic Disease
Smiles
N[C@@H](CC(O)=O)C(N[C@H](C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@H](C(NCC(N([C@@H](CC(C)C)C(N[C@@H](CCCC)C(N)=O)=O)C)=O)=O)C(C)C)=O)=O)CCCCN)=O
Molecular Formula
C39H65N9O10
Molecular Weight
819.99
References & Citations
[1]Gustafsson M B F, et al. Compounds and their use in treatment of tachykinin receptor mediated disorders. WO2022096736A1. 2022-05-12.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
NK2R; NK3R
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 8/18 (C-51), CF405S conjugate, 0.1mg/mL
MART-1 / Melan-A (M2-7C10), CF405S conjugate, 0.1mg/mL
CD50 / ICAM3 (ICAM3/2873R), CF405S conjugate, 0.1mg/mL
CELA3B (CELA3B/1218), CF568 conjugate, 0.1mg/mL
